-
‣Latest News
Jan 17, 2012
TrovaGene Presentation [8k filing]: Introduction to TrovaGene, Antonius Schuh, CEO
Jan 6, 2012
TrovaGene Acquires CLIA - Certified Laboratory
Jan 3, 2012
TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
Dec 7, 2011
Antonius Schuh, Ph.D. Joins TrovaGene, Inc. As Chief Executive Officer
Sept 7, 2011
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
August 10, 2011
TrovaGene, Inc. Confirms It Has Regained Its Rights to Transrenal Technology for Non-Invasive Prenatal Testing and Cancer
October 13, 2010
TrovaGene, Inc., Announce Issuance of U.S. Patent for Diagnosis and Monitoring of Pathogenic Infection
June 21, 2010
TrovaGene Announces a Licensing Agreement with Skyline Diagnostics to Use Its NPM1 Technology for Laboratory Testing Services in Europe
April 15, 2010
TrovaGene Announces the Formation of Its Scientific Advisory Board
TROV.PK
TROVAGENE INC (TROV.PK)
